Project Grant R01HL179076
Award Date
5/15/25
Completion Date
2/28/29
Dollars Obligated
$355K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will support a $187,500 research project at North Carolina Central University (NCCU) from September 2024 to July 2028. The project aims to investigate whether exposure to e-cigarette (vaping) liquids renders the lung more susceptible to pulmonary distress and disease. The research will utilize an ex vivo human bronchial epithelial cell...
This Project Grant award of $3,002,492 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund research to assess the impact of e-cigarette use on pulmonary function in young healthy adults. The research will use an advanced imaging technique called hyperpolarized xenon-129 MRI (HXEMRI) to quantify early physiological changes in the lungs of e-cigarette users compared to non-users. The project will also evaluate the ability of a...
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) provides $549,555.45 to The Trustees of the University of Pennsylvania to investigate the respiratory health effects and chemical exposures associated with the use of electronic cigarette (e-cigarette) devices, particularly new disposable products, among young adults. The key objectives are to:...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $900,000 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Louisiana State University (LSU) to study the impact of prenatal exposure to copper from electronic nicotine delivery system (ENDS) aerosols on the neonatal pulmonary immune system and its association with the development of asthma. The research aims to determine the mechanisms by which prenatal ENDS exposure modulates the neonatal pulmonary...
This federal Project Grant award from the National Institute of Environmental Health Sciences (NIEHS), under the Environmental Health (CFDA 93.113) program, is for a research project titled "Xanthine Oxidase Mediates the Vascular Dysfunction with Direct and In-Utero Electronic Cigarette Exposure." The $619,477 grant, awarded on September 1, 2024, will fund a study by the West Virginia University Research Corporation to investigate the role of the enzyme xanthine oxidase in the...
This $909,000 project grant from the National Institutes of Health's National Institute of Child Health and Human Development will fund research at Brigham Young University exploring the role of the receptor for advanced glycation end-products (RAGE) signaling pathway in placenta and lung inflammation due to secondhand smoke and e-cigarette vapor exposure. The two-year award beginning July 13, 2022 supports two specific aims utilizing molecular methodologies with undergraduate students to test...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $230,618 to investigate the generation of a novel toxic compound from vaping vitamin E acetate (a-tocopherol-acetate) and its potential to induce fever, lung inflammation, and damage in youth and adults. The project aims to 1) characterize the chemical structure of this novel high molecular weight compound generated...
This $720,855 Project Grant award from the National Institute of Environmental Health Sciences (CFDA 93.113 - Environmental Health) supports the "ENDS Aerosol Particle Deposition, In Utero Exposures and Children's Respiratory Health Effects (ENDURE)" research consortium. The project aims to investigate the respiratory health impacts of in utero exposures to electronic nicotine delivery system (ENDS) aerosols, with a focus on e-cigarettes. Key products and services to be delivered...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $740,338 to the University of Cincinnati to study the role of Protease Activated Receptor 2 (PAR2) in the initiation and progression of abdominal aortic aneurysm (AAA). The research aims to determine the effect of VSMC-specific PAR2 deletion and PAR2 inhibition in mouse models of aneurysmal disease, as well as delineate how PAR2...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), supports research under the Cardiovascular Diseases Research program (CFDA 93.837). The $169,560 grant awarded to the Regents of the University of Michigan aims to investigate the role of the PERK/EIF2A/ATF4 endoplasmic reticulum stress response and MLL1-mediated regulation of CHOP gene expression in vascular smooth muscle cell (VSMC) apoptosis and...